Topchoice Medical Co Stock

Topchoice Medical Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Topchoice Medical Co (600763.SS) as of Jul 26, 2026 is 28.68. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 28.14 — a change of 1.90% (higher).

EV/EBIT

28.68

YoY

1.90%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Topchoice Medical Co is 2026 28.68 . EV/EBIT (Enterprise Value to EBIT) of Topchoice Medical Co was 2025 28.14 . It decreases by 1.90% higher compared to the previous year.

The Topchoice Medical Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
36.83 base
Jan 1, 2020
95.27 base
Jan 1, 2021
67.03 base
Jan 1, 2022
65.21 base
Jan 1, 2023
34.58 base
Jan 1, 2024
28.65 base
Jan 1, 2025 (e)
24.17 base
Jan 1, 2026 (e)
18.38 base
YEARPRICE-TO-EBIT
2026 est 18.38
2025 est 24.17
2024 28.65
2023 34.58
2022 65.21
2021 67.03
2020 95.27
2019 36.83
2018 24.48
2017 25.74
2016 44.08
2015 61.37
2014 39.65
2013 26.68
2012 19.94
2011 24.89
2010 33.28
2009 28.42
2008 24.74
2007 55.90
2006 80.27
2005 292.72
Access this data via the Eulerpool API
Get Free API Key

Topchoice Medical Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Topchoice Medical Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Topchoice Medical Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Topchoice Medical Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Topchoice Medical Co grows earnings faster than its peers.

Topchoice Medical Co Stock analysis

What does Topchoice Medical Co do? Topchoice Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Topchoice Medical Co stock

EV/EBIT (Enterprise Value to EBIT) of Topchoice Medical Co is 28.68 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Topchoice Medical Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Topchoice Medical Co